Stifel Nicolaus Starts CymaBay Therapeutic (CBAY) at Buy
Tweet
Share
E-mailGet Alerts CBAY Hot Sheet
Price: $32.48 --0%
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
7 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Stifel Nicolaus initiated coverage on CymaBay Therapeutic (NASDAQ: CBAY) with a Buy rating and a price target of $10.00.
For an analyst ratings summary and ratings history on CymaBay Therapeutic click here. For more ratings news on CymaBay Therapeutic click here.
Shares of CymaBay Therapeutic closed at $7.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Tower Semiconductor (TSEM) at Buy, Top Pick
- Stifel Starts GlobalFoundries Inc. (GFS) at Buy, Top Pick
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
